chloroquine has been researched along with thyroxine in 14 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 7 (50.00) | 18.7374 |
1990's | 2 (14.29) | 18.2507 |
2000's | 1 (7.14) | 29.6817 |
2010's | 4 (28.57) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Ahlin, G; Artursson, P; Bergström, CA; Gustavsson, L; Karlsson, J; Larsson, R; Matsson, P; Norinder, U; Pedersen, JM | 1 |
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
Artursson, P; Haglund, U; Karlgren, M; Kimoto, E; Lai, Y; Norinder, U; Vildhede, A; Wisniewski, JR | 1 |
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
Blondeau, JP; Francon, J; Osty, J | 1 |
Ito, S; Nishikawa, M; Tamura, T | 1 |
Ito, S | 1 |
Domenjoz, R; Kalbhen, DA; Wisgens, D | 1 |
Ozawa, K; Shichijo, K; Takemura, Y; Yamada, T | 1 |
Hugues, FC; Le Jeunne, C; Munera, Y; Pays, JF | 1 |
Harney, J; Larsen, PR; Steinsapir, J | 1 |
GROGG, E | 1 |
HAUSS, WH; JUNGE-HUELSING, G | 1 |
Hudaverdı, O; Keser, G; Kobak, S; Oksel, F | 1 |
1 review(s) available for chloroquine and thyroxine
Article | Year |
---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
13 other study(ies) available for chloroquine and thyroxine
Article | Year |
---|---|
Structural requirements for drug inhibition of the liver specific human organic cation transport protein 1.
Topics: Cell Line; Computer Simulation; Drug Design; Gene Expression Profiling; Humans; Hydrogen Bonding; Liver; Molecular Weight; Organic Cation Transporter 1; Pharmaceutical Preparations; Predictive Value of Tests; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Structure-Activity Relationship | 2008 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Classification of inhibitors of hepatic organic anion transporting polypeptides (OATPs): influence of protein expression on drug-drug interactions.
Topics: Atorvastatin; Biological Transport; Drug Interactions; Estradiol; Estrone; HEK293 Cells; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; In Vitro Techniques; Least-Squares Analysis; Liver; Liver-Specific Organic Anion Transporter 1; Models, Molecular; Multivariate Analysis; Organic Anion Transporters; Organic Anion Transporters, Sodium-Independent; Protein Isoforms; Pyrroles; Solute Carrier Organic Anion Transporter Family Member 1B3; Structure-Activity Relationship; Transfection | 2012 |
Characterization of the thyroid hormone transport system of isolated hepatocytes.
Topics: Animals; Biological Transport, Active; Cadaverine; Chloroquine; Hydrogen-Ion Concentration; Kinetics; Liver; Male; Membrane Potentials; Prealbumin; Rats; Rats, Inbred Strains; Stereoisomerism; Temperature; Thyroid Hormones; Thyroxine; Triiodothyronine | 1988 |
Effects of desiccated thyroid, prednisolone and chloroquine on goiter and antibody titer in chronic thyroiditis.
Topics: Agglutination Tests; Autoantibodies; Autoimmune Diseases; Chloroquine; Chronic Disease; Complement Fixation Tests; Complement System Proteins; Female; gamma-Globulins; Goiter; Humans; Male; Prednisolone; Thyroid Hormones; Thyroiditis; Thyroxine | 1968 |
[Thyroid hormones].
Topics: Androgens; Chloroquine; Diethylstilbestrol; Estrogens; Female; Humans; Hydrocortisone; Hydroflumethiazide; Hyperthyroidism; Hypothyroidism; In Vitro Techniques; Male; Prednisolone; Pregnancy; Salicylates; Serum Globulins; Testosterone; Thyroid Function Tests; Thyroxine; Thyroxine-Binding Proteins; Tolbutamide | 1967 |
[Effect of small doses of anti-inflammatory agents on sulfate-S35 incorporation and cell proliferation of neoplastic mast cells in vitro].
Topics: Amides; Anti-Inflammatory Agents; Butyrates; Cell Division; Chloroquine; Culture Techniques; Dinitrophenols; Flufenamic Acid; Glycosaminoglycans; Indomethacin; Mast Cells; Mast-Cell Sarcoma; Mefenamic Acid; Naphthalenes; Phenylbutazone; Prednisolone; Sodium Salicylate; Sulfates; Sulfur Isotopes; Thyroxine | 1970 |
Comparison of the effects of several drugs on tissue uptake of labeled thyroxine and triiodothyronine in the presence of rat plasma in vitro.
Topics: Animals; Chloroquine; Coloring Agents; Dinitrophenols; In Vitro Techniques; Isoniazid; Liver; Methylene Blue; Muscles; Novobiocin; Pituitary Gland; Quinine; Rats; Rose Bengal; Salicylates; Surface-Active Agents; Thyroxine; Triiodothyronine; Trypan Blue | 1966 |
Interaction of thyroxine sodium with antimalarial drugs.
Topics: Antimalarials; Chloroquine; Drug Interactions; Drug Therapy, Combination; Female; Humans; Hypothyroidism; Malaria, Falciparum; Middle Aged; Proguanil; Thyroxine | 1997 |
Type 2 iodothyronine deiodinase in rat pituitary tumor cells is inactivated in proteasomes.
Topics: Adenosine Triphosphate; Animals; Carbonyl Cyanide m-Chlorophenyl Hydrazone; Chloroquine; Cycloheximide; Cysteine Endopeptidases; Cytochalasin B; Iodide Peroxidase; Iodothyronine Deiodinase Type II; Isoenzymes; Leupeptins; Multienzyme Complexes; Neoplasm Proteins; Pituitary Neoplasms; Protease Inhibitors; Proteasome Endopeptidase Complex; Protein Synthesis Inhibitors; Rats; Thyroxine; Triiodothyronine, Reverse; Tumor Cells, Cultured; Ubiquitins | 1998 |
[On the drug modification of experimental porphyria in rabbits].
Topics: Animals; Ascorbic Acid; Chloroquine; Lagomorpha; Porphyrias; Rabbits; Thyroxine; Vitamins | 1960 |
[Changes in connective tissue metabolism by toxic, infectious and allergic influences].
Topics: Aging; Chloroquine; Chondroitin; Communicable Diseases; Connective Tissue; Cortisone; Humans; Thyroxine | 1961 |
Coexistence of systemic lupus erythematosus, Hashimoto's thyroiditis and IgA nephropathy in the same patient.
Topics: Angiotensin-Converting Enzyme Inhibitors; Chloroquine; Drug Therapy, Combination; Female; Glomerulonephritis, IGA; Glucocorticoids; Hashimoto Disease; Humans; Lupus Erythematosus, Systemic; Middle Aged; Thyroxine; Treatment Outcome | 2011 |